Finance

Beta
Lists
BKGI:BKK
Bangkok Genomics Innovation PCL
THB 2.00
+0.50%
(+0.0100) 1D
Jun 2, 4:40:00 PM GMT+7  ·   THB
All symbols
SymbolPriceChange% Change
Generating top insights for BKGI...
Open
THB 2.08
High
THB 2.22
Low
THB 2.00
Mkt. cap
1.20B
Avg. vol.
1.18M
Volume
10.29M
Dividend
2.50%
Quarterly dividend
THB 0.01
Ex-dividend date
May 6, 2026
P/E ratio
17.53
52-wk high
THB 2.22
52-wk low
THB 1.11
EPS
THB 0.11
Shares outstanding
600.00M
No. of employees
109
Open
THB 2.08
High
THB 2.22
Low
THB 2.00
Mkt. cap
1.20B
Avg. vol.
1.18M
Volume
10.29M
Dividend
2.50%
Quarterly dividend
THB 0.01
Ex-dividend date
May 6, 2026
P/E ratio
17.53
52-wk high
THB 2.22
52-wk low
THB 1.11
EPS
THB 0.11
Shares outstanding
600.00M
No. of employees
109
News stories
From sources across the web
About Bangkok Genomics Innovation PCL
CEO-
Employees109
FoundedSep 11, 2017
Headquarters-
SectorHealth care provider
Websitebangkokgenomics.com
Previous reportsAll values in THB
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in THB
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
69.80M
88.92M
142.26M
152.18M
Cost of goods sold
40.79M
55.20M
82.83M
87.50M
Cost of revenue
40.79M
55.20M
82.83M
87.50M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25.36M
26.09M
32.35M
29.00M
Operating expense
24.41M
26.12M
30.77M
28.75M
Total operating expenses
65.19M
81.32M
113.60M
116.24M
Operating income
4.60M
7.60M
28.66M
35.93M
Other non operating income
-
-
-
-
EBT including unusual items
4.12M
7.15M
28.30M
35.55M
EBT excluding unusual items
4.12M
7.15M
28.30M
35.55M
Income tax expense
-166.00K
233.00K
2.30M
4.32M
Effective tax rate
-4.03%
3.26%
8.12%
12.17%
Other operating expenses
-1.58M
-1.22M
-1.96M
-970.00K
Net income
4.30M
6.93M
26.01M
31.23M
Net profit margin
6.15%
7.79%
18.28%
20.52%
Earnings per share
0.01
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-359.00K
-353.00K
-354.95K
-336.00K
Net interest expenses
-359.00K
-353.00K
-354.95K
-336.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
8.75M
11.82M
32.52M
40.73M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer